Carson Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$718K Buy
781
+46
+6% +$46.6K 0.37% 62
2025
Q4
$790K Hold
735
0.41% 58
2025
Q3
$561K Buy
735
+88
+14% +$65.5K 0.3% 75
2025
Q2
$504K Buy
647
+25
+4% +$19.4K 0.32% 72
2025
Q1
$514K Sell
622
-25
-4% -$20.8K 0.35% 71
2024
Q4
$499K Sell
647
-392
-38% -$325K 0.35% 68
2024
Q3
$921K Buy
1,039
+127
+14% +$114K 0.58% 46
2024
Q2
$826K Sell
912
-5
-0.5% -$4K 0.58% 45
2024
Q1
$713K Sell
917
-49
-5% -$34.9K 0.5% 61
2023
Q4
$563K Sell
966
-90
-9% -$52.5K 0.44% 75
2023
Q3
$567K Sell
1,056
-9
-0.8% -$4.64K 0.5% 69
2023
Q2
$500K Sell
1,065
-99
-9% -$41.5K 0.42% 82
2023
Q1
$400K Buy
1,164
+1
+0.1% +$337 0.36% 84
2022
Q4
$426K Buy
1,163
+15
+1% +$5.32K 0.41% 67
2022
Q3
$371K Sell
1,148
-159
-12% -$50.4K 0.41% 66
2022
Q2
$424K Buy
1,307
+176
+16% +$52.8K 0.47% 62
2022
Q1
$324K Buy
1,131
+1
+0.1% +$257 0.32% 79
2021
Q4
$312K Buy
+1,130
New +$286K 0.32% 83

Other funds holding LLY

Carson Advisory's LLY Position: Q1 2026 in Review

Carson Advisory increased its Eli Lilly (LLY) stake by 6.3% in Q1 2026, buying an estimated $46.6K and bringing the position to 781 shares worth $718K. The position accounts for 0.37% of the portfolio, ranked #62.

Carson Advisory first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $921K in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Carson Advisory held 781 shares of Eli Lilly worth $718K as of Q1 2026.
  • Carson Advisory bought 46 Eli Lilly shares in Q1 2026, an estimated $46.6K.
  • Eli Lilly made up 0.37% of Carson Advisory's portfolio in Q1 2026, its #62 holding.
  • Carson Advisory first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Carson Advisory's Eli Lilly position peaked at $921K in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Carson Advisory's 13F filing for Q1 2026, filed 7 May 2026.